The Journal of Biological Inorganic Chemistry has officially retracted a highly cited 2017 study on the toxicity of silver nanoparticles following an investigation that uncovered extensive image duplication. The retraction note, published on June 15, 2026, cites severe concerns regarding the scientific soundness of the figures presented, which represented cells and tissues under supposedly different experimental conditions.
The original research, titled "Surface modification minimizes the toxicity of silver nanoparticles: an in vitro and in vivo study," was authored by a team of researchers primarily affiliated with Vidyasagar University and Calcutta University in India. The paper explored how coating silver nanoparticles (AgNPs) with bovine serum albumin (BSA) or polyethylene glycol (PEG) could mitigate their toxic effects. However, the Editor-in-Chief stated that confidence in the integrity of the research has been entirely lost.
The Image Duplication Findings
An investigation conducted after the paper's publication revealed multiple instances where panels representing distinct experimental variables were reused. The specific issues identified include:
- The 50 µg/ml / BSA coated AgNPs panel in Figure 11 appears to overlap with the 2 mg/kg BW / AgNPs panel in Figure 17.
- The 10 µg/ml and 25 µg/ml panels in the PEG coated AgNPs row of Figure 12 appear to overlap.
- The 10 µg/ml / Ag@BSA-NPs and 50 µg/ml / AgNPs panels in Figure 13 appear to overlap.
- The 25 µg/ml and 50 µg/ml panels in the Ag@PEG-NPs row of Figure 13 appear to overlap.
- The Ag@PEG-NPs and Ag@BSA-NPs panels in the Spleen row of Figure 21 appear to overlap.
According to the publisher's note, authors Balaram Das, Sandeep Kumar Dash, and Aditi Dey explicitly disagree with the retraction. The remaining eight authors, including corresponding author Somenath Roy, did not respond to correspondence from Springer Nature regarding the decision.
The Growing Scrutiny on Nanotoxicity Data
The retraction of this silver nanoparticles study highlights a critical vulnerability in nanomedicine research: the heavy reliance on visual assays to prove cellular safety. When panels representing different concentrations or entirely different tissues - like the spleen - overlap, it fundamentally breaks the trust required to advance these materials into clinical trials.
This case also underscores the increasing effectiveness of post-publication scrutiny in the academic community. As automated image-checking tools and dedicated peer-review watchdogs become standard in scientific publishing, we are likely to see a continued wave of retractions for older papers. While disruptive, this process forces a necessary correction of the scientific record, ensuring that future biomedical engineering is built on verifiable data.
